(Q42687457)

English

Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer

scientific article published on 12 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

6

object named as

Wassim Kassouf

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

object named as

Faysal A Yafi

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Fadi Brimo

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Manon Auger

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Armen Aprikian

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Simon Tanguay

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

12 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

27.e1-6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Natural history and treatment of low and high risk superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Superficial bladder cancer: progression and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Surveillance for bladder cancer: the management of 4.8 million people. South-west Urologists

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

URINE SEDIMENT SMEARS AS A DIAGNOSTIC PROCEDURE IN CANCERS OF THE URINARY TRACT

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Reliability of the routine cytological diagnosis in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Biomarkers for detection and surveillance of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Non-invasive urothelial neoplasms: according to the most recent WHO classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Accuracy of urine cytology and the significance of an atypical category.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

The accuracy of urinary cytology in daily practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Urine cytology discrepancies: frequency, causes, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Urinary markers in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.09.011

7 January 2021

Identifiers

10.1016/J.UROLONC.2012.09.011

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42687457&oldid=2110589170"